| Molecular mechanisms and future implications of VEGF/VEGFR in cancer therapy SA Patel, MB Nilsson, X Le, T Cascone, RK Jain, JV Heymach Clinical Cancer Research 29 (1), 30-39, 2023 | 78 | 2023 |
| Characterization of the immune landscape of EGFR-mutant NSCLC identifies CD73/adenosine pathway as a potential therapeutic target X Le, MV Negrao, A Reuben, L Federico, L Diao, D McGrail, M Nilsson, ... Journal of thoracic oncology 16 (4), 583-600, 2021 | 72 | 2021 |
| Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1 V Krishnan, S Tallapragada, B Schaar, K Kamat, AM Chanana, Y Zhang, ... Communications biology 3 (1), 524, 2020 | 72 | 2020 |
| Nonequilibrium Reactivation of Na+ Current Drives Early Afterdepolarizations in Mouse Ventricle AG Edwards, E Grandi, JE Hake, S Patel, P Li, S Miyamoto, JH Omens, ... Circulation: Arrhythmia and Electrophysiology 7 (6), 1205-1213, 2014 | 46 | 2014 |
| Altered regulation of HIF-1α in naive-and drug-resistant EGFR-mutant NSCLC: implications for a vascular endothelial growth factor-dependent phenotype MB Nilsson, J Robichaux, MH Herynk, T Cascone, X Le, Y Elamin, S Patel, ... Journal of Thoracic Oncology 16 (3), 439-451, 2021 | 38 | 2021 |
| CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance MB Nilsson, Y Yang, S Heeke, SA Patel, A Poteete, H Udagawa, ... Cancer Cell 41 (2), 340-355. e6, 2023 | 28 | 2023 |
| IL6 Mediates Suppression of T-and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC SA Patel, MB Nilsson, Y Yang, X Le, HT Tran, YY Elamin, X Yu, F Zhang, ... Clinical Cancer Research 29 (7), 1292-1304, 2023 | 24 | 2023 |
| Estrogen promotes resistance to bevacizumab in murine models of NSCLC SA Patel, MH Herynk, T Cascone, B Saigal, MB Nilsson, H Tran, ... Journal of Thoracic Oncology 16 (12), 2051-2064, 2021 | 10 | 2021 |
| Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma L Hong, WE Lewis, M Nilsson, S Patel, S Varghese, MJ Rivera, RR Du, ... Cancers 14 (14), 3473, 2022 | 5 | 2022 |
| Study on Standardization of Starch Extraction Time from Rhizomes of Tikhur (Curcuma angustifolia Roxb.) D Shankar, S Patel, MK Sahu, SC Mukherjee International Journal of Agricultural Engineering, 436-441, 2014 | 3 | 2014 |
| EGFR CAR-NK cells demonstrate potent activity against EGFR TKI resistant NSCLC Y Yang, M Nilsson, S Patel, J Robichaux, A Poteete, X Yu, F Zhang, ... Cancer Research 82 (12_Supplement), 548-548, 2022 | 2 | 2022 |
| ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC NI Vokes, A Galan Cobo, M Fernandez-Chas, D Molkentine, S Treviño III, ... Clinical Cancer Research 29 (23), 4958-4972, 2023 | 1 | 2023 |
| CD70 is a novel therapeutic target for EGFR mutant NSCLC with acquired, EMT-associated EGFR TKI resistance MB Nilsson, Y Yang, S Patel, S Heeke, X Le, T Aruguman, J Robichaux, ... Cancer Research 82 (12_Supplement), 1827-1827, 2022 | 1 | 2022 |
| Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment AR Parikh, BH Chee, J Tsai, TA Rich, KS Price, SA Patel, L Zhang, ... Clinical Cancer Research, 2024 | | 2024 |
| CD70-targeting CAR-T and CAR-NK cells demonstrate potent activity against NSCLC drug-tolerant persister cells Y Yang, M Nilsson, S Patel, X Yu, A Poteete, Q Huang, S Heeke, ... Cancer Research 83 (7_Supplement), 891-891, 2023 | | 2023 |
| Targeting IL-6/STAT3 signaling in EGFR-mutant drug tolerant persister cells SA Patel, M Nilsson, Y Yang, L Shen, J Wang, A Poteete, X Yu, X Ren, ... Cancer Research 83 (7_Supplement), 3864-3864, 2023 | | 2023 |
| Clinical and transcriptomic analysis demonstrates improved survival and unique gene expression signatures among SCLC arising in patients with minimal tobacco use K Concannon, S Heeke, M Sahu, X Tang, K Sasaki, S Patel, MG Raso, ... Cancer Research 83 (7_Supplement), 1398-1398, 2023 | | 2023 |
| Uncovering Molecular Targets To Overcome Immunosuppression In Non-Small Cell Lung Cancer With Acquired Tki Resistance SA Patel | | 2023 |
| Suppression of macrophage migration inhibitory factor (MIF) impairs tumor growth and overcomes immunotherapy resistance in KEAP1-deficient NSCLC tumors A Galan-Cobo, Y Qian, F Peng, DJ McGrail, S Patel, F Zhang, X Zhang, ... Cancer Research 82 (12_Supplement), 2113-2113, 2022 | | 2022 |
| Targeting nonsense-mediated decay restores p53 function in HPV-associated head and neck cancers J Gudikote, T Cascone, A Poteete, P Sitthideatphaiboon, S Patel, Y Yang, ... Cancer Research 82 (12_Supplement), 5733-5733, 2022 | | 2022 |
